Breathe Well Live Well
|
Sandoz Launches Breathe Africa Program to Improve Asthma Diagnosis, Treatment …
CSRwire.com (press release) Holzkirchen, Jul. 24 /CSRwire/ – Sandoz today announced the launch of Breathe Africa, a respiratory health program aimed at improving the diagnosis and treatment of asthma through sharing medical expertise and donating medicines. The program will start … |
View full post on asthma – Google News
|
Sandoz Launches Breathe Africa Program to Improve Asthma Diagnosis, Treatment …
3BL Media (press release) Holzkirchen, July 24, 2015 /3BL Media/ – Sandoz today announced the launch of Breathe Africa, a respiratory health program aimed at improving the diagnosis and treatment of asthma through sharing medical expertise and donating medicines. The program … |
View full post on asthma – Google News
2 Minute Medicine |
Syndecan-4 identified as novel target for asthma treatment [PreClinical]
2 Minute Medicine Study Rundown: Asthma, an immune system disorder characterized by airway inflammation and difficulty breathing, affects about 25 million people in the United States alone. Both long- and short-term medications are available for regulating inflammation … |
View full post on asthma – Google News
Bloomberg |
A $20,000 Lung-Searing Asthma Treatment Disappoints in Sales – Bloomberg …
Bloomberg Two years ago, Christi Thompson's doctor put her under anesthesia, slipped an electrode-tipped catheter into her lungs, and used its hot end to sear the walls of her airways, thinning the enlarged muscle that cuts off a patient's air during an asthma … |
View full post on asthma – Google News
Bloomberg |
A $20000 Lung-Searing Asthma Treatment Disappoints in Sales
Bloomberg Two years ago, Christi Thompson's doctor put her under anesthesia, slipped an electrode-tipped catheter into her lungs, and used its hot end to sear the walls of her airways, thinning the enlarged muscle that cuts off a patient's air during an asthma … A $20000 Lung-Searing Asthma Treatment Disappoints in Sales (1) |
View full post on asthma – Google News
|
San Diego Source > News > A $20,000 Lung-Searing Asthma Treatment …
San Diego Source (subscription) Pressure is building on insurers after the American College of Allergy, Asthma and Immunology gave its support for the procedure, bronchial thermoplasty, earlier this month, joining six other health organizations. About 26 million Americans have asthma. |
View full post on asthma – Google News
HeraldNet |
New treatment calms asthma attacks' severity
HeraldNet The Centers for Disease Control and Prevention reported that in 2010, 13.9 million people in the U.S. experienced asthma attacks. There were 2.1 million emergency department visits for asthma and 3,388 asthma-related deaths. |
View full post on asthma – Google News
|
Boston Scientific Bronchial Thermoplasty Treatment Recognized By American …
PR Newswire (press release) "Allergists see a wide range of adult asthma patients – some of whom suffer from asthma that can not be controlled with available therapeutic regimens," said allergist James Sublett, MD, ACAAI president. "The scientific literature supports bronchial … |
View full post on asthma – Google News
Adult Orbital Xanthogranulomatous Disease: A Review with Emphasis on Etiology, Systemic Associations, Diagnostic Tools, and Treatment.
Dermatol Clin. 2015 Jul;33(3):457-63
Authors: Kerstetter J, Wang J
Abstract
Adult orbital xanthogranulomatous diseases are rare entities and encompass a group of disorders with varying manifestations that are poorly understood. Taken as a group, there are non-Langerhans histiocytic disorders (type II) that are diagnosed histologically by the presence of foamy histiocytes, Touton giant cells, and varying degrees of fibrosis. Based on the accompanying systemic associations, there are 4 main categories of adult xanthogranulomatous disease: adult-onset xanthogranuloma, adult-onset asthma and periocular xanthogranuloma, necrobiotic xanthogranuloma, and Erdheim-Chester disease. Herein, we discuss the etiopathogenesis, systemic associations, methods of diagnosis, and treatment options for these disorders.
PMID: 26143425 [PubMed – in process]
View full post on pubmed: asthma
Conditions: Chronic Obstructive Pulmonary Disease; Asthma; Overlap Syndrome
Interventions: Drug: LABA + LAMA; Drug: ICS; Drug: LABA + LAMA + ICS; Drug: LABA + ICS; Drug: other
Sponsor: Katholieke Universiteit Leuven
Not yet recruiting – verified June 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days